Skip to main content

Table 2 Adverse events

From: Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

  Vaccinated patients
(n = 21)a
 
  Grade 1–2 Grade ≥ 3
Reported toxicity (CTCAE 4.0)   
Any toxicity 21 0
Anemia 15 0
Flu-like symptomsb 10 0
Hypoalbuminemia 10 0
Fatiguec 8 0
Upper respiratory infection 4 0
Dizziness 3 0
Hematoma 3 0
Lymphopenia 3 0
Hypophosphatemia 3 0
Injection site reaction 2 0
Fever 2 0
Headached 2 0
AST 2 0
Otherse 1 0
  1. AST aspartate aminotransferase, CTCAE 4.0 Common Terminology Criteria for Adverse Events version 4.0
  2. aattributed by investigators
  3. bflu-like symptoms include fever, fatigue, chills, body aches, malaise, loss of appetite and headache
  4. cfatigue was mentioned separately when it lasted at least 1 day longer than the other flu-like symptoms or when it was present without the other flu-like symptoms
  5. dheadache was mentioned separately when it was present apart from flu-like symptoms
  6. eothers include nausea (5%), vomiting (5%), diarrhea (5%), neutropenia (5%), eosinophilia (5%), thrombocytopenia (5%), increased bilirubine (5%) and gamma-glutamyltransferase (5%)